project id: TCGA-THCA; case submitter id: TCGA-DJ-A2PR; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.0; age at index: 27; days to birth: -9914; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1984; age at diagnosis: 9914; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage I; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 835.0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: Not Reported; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 155; days to sample procurement: 0; initial weight: 450.0; portion submitter id: TCGA-DJ-A2PR-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 50.0; percent tumor nuclei: 100.0;